Abstract
Pre- and probiotics (synbiotics) are suggested to have beneficial effects on human health. This study describes effects of an amino acid based formula (AAF) with synbiotics in infants with cow’s milk allergy (CMA). In a prospective, randomized, double-blind controlled study, full term infants with diagnosed IgE and/or non-IgE mediated CMA received a commercially available AAF (NEO; n=56) or an AAF with synbiotics (neutral and acidic oligosaccharides, Bifidobacterium breve M-16V) (NEO-SYN; n=54) for 16 weeks. Primary outcome was growth and formula tolerance; secondary outcomes were dermatological/respiratory allergic characteristics, and stool characteristics recorded in subject diaries and evaluated by a physician. Furthermore, adverse events and concomitant medications used during the study were reported. Average age of infants at inclusion was 4.5±2.4 months. Overall, NEO-SYN and NEO were equally tolerated and both supported normal growth. Both formulas reduced allergic symptoms; SCORAD decreased in both groups with no significant differences in SCORAD change over 16 weeks between both groups. Softer and yellow/brown stools were reported more frequently in the NEO-SYN group compared to more dry and green/dark brown stools in the NEO group (week 0-2, p=0.035; week 2-4, p=0.010 for stool consistency). Furthermore, the NEO-SYN group had less subjects with reported infections (p=0.008) and less subjects receiving medication for functional gastrointestinal disorders (p=0.029) when compared with the NEO group. In addition the NEO-SYN group had a lower number of infants on antibiotics (p=0.049), especially amoxicillin (p=0.004). This study shows that an AAF with synbiotics is equally tolerated, supports normal growth and is similarly effective in the management of CMA symptoms compared to an AAF without synbiotics. Infants taking an AAF with this synbiotic blend have different stool characteristics, less reported infections and less antibiotic use, which suggests that addition of the synbiotics to an AAF improves resistance to infections and reduces specific medication use.
Highlights
Pre- and probiotics are suggested to have beneficial effects on human health
This study describes effects of an amino acid based formula (AAF) with synbiotics in infants with cow’s milk allergy (CMA)
Primary outcome was growth and formula tolerance; secondary outcomes were dermatological/respiratory allergic characteristics, and stool characteristics recorded in subject diaries and evaluated by a physician
Summary
O23 - Functional effects of an amino-acid based formula with synbiotics in cow’s milk allergic infants Pre- and probiotics (synbiotics) are suggested to have beneficial effects on human health. This study describes effects of an amino acid based formula (AAF) with synbiotics in infants with cow’s milk allergy (CMA).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
